Stay updated on Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.

Latest updates to the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.3 was added to the history, replacing the previous v3.5.2 entry.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew history entry Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed from the study record history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedAdded Revision: v3.5.0 and Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision in the footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision (v3.4.2) was added to the history, and an older funding notice and revision entry (v3.4.1) were removed.SummaryDifference0.6%

- Check91 days agoChange DetectedAdministrative updates: the history page shows a new funding/operating-status notice and changes the revision tag to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.